Bayesian hypothesis testing with frequentist characteristics in clinical trials

Area of Science:

• Biostatistics
• Clinical Trial Methodology
• Statistical Inference

Background:

• Bayesian methodologies offer potential advantages in clinical trials by incorporating historical data through informative priors.
• However, reconciling Bayesian approaches with traditional frequentist methods regarding hypothesis formulation and type I error control remains a challenge.
• The precise application of priors for data analysis, type I error control, and sample size calculation requires further clarification.

Purpose of the Study:

• To investigate the application of inferential, null, and design priors in Bayesian data analysis for clinical trials.
• To clarify type I error control and sample size calculation within Bayesian frameworks, particularly concerning the use of historical data.
• To evaluate methods for ensuring the validity of Bayesian analyses that borrow historical information, addressing potential inconsistencies.

Main Methods:

• Application of inferential prior, null prior, and design prior for Bayesian data analysis, type I error control, and sample size calculation.
• Theoretical demonstration that type I error control inherently prevents the incorporation of favorable prior information.
• Utilizing calibrated critical values from simulations with commensurate or power priors to eliminate historical information borrowing.
• Employing dynamic borrowing via commensurate or power priors to adjust for varying degrees of data consistency between historical and current studies.

Main Results:

• Type I error control in Bayesian analysis, when properly implemented, effectively prevents the use of favorable historical data.
• Calibrated critical values derived from simulations using specific priors (commensurate, power) ensure that historical data is not inappropriately borrowed.
• The validity of borrowing historical data hinges on the a priori assumption of consistency between historical and current study data.
• Dynamic borrowing mechanisms allow for flexible integration of historical data based on observed data consistency.

Conclusions:

• Bayesian methods can effectively utilize historical data in clinical trials, but careful control of type I error is paramount.
• The choice and application of priors, along with methods for assessing data consistency, are crucial for valid Bayesian inference.
• Dynamic borrowing offers a robust approach to leverage historical information while mitigating risks associated with data inconsistency.